- BioSig Technologies Expands Intellectual Property Portfolio
- AquaBounty Technologies to Present at the June 2020 Virtual Investor Summit
- Author’s Journey to Success in Science Leads to New Book on the American Dream
- First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (γδ) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma
- Aeglea BioTherapeutics to Present at BIO Digital 2020
- Michael White, Ph.D. joins Samumed as Chief Scientific Officer
- ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-viral Candidate for Treatment of COVID-19
- Microbix Engaged to Develop & Supply Custom QAPs
- Mateon Provides Update on OT-101
- Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
